Literature DB >> 12861081

Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics.

Charles N Serhan1, Bruce Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12861081      PMCID： PMC166355          DOI： 10.1073/pnas.1733589100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  27 in total

Review 1.  Genetic and pharmacological analysis of prostanoid receptor function.

Authors:  S Narumiya; G A FitzGerald
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  The coxibs, selective inhibitors of cyclooxygenase-2.

Authors:  G A FitzGerald; C Patrono
Journal:  N Engl J Med       Date:  2001-08-09       Impact factor: 91.245

3.  Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia.

Authors:  C Bandeira-Melo; M F Serra; B L Diaz; R S Cordeiro; P M Silva; H L Lenzi; Y S Bakhle; C N Serhan; M A Martins
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

4.  Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence.

Authors:  M N Muscará; N Vergnolle; F Lovren; C R Triggle; S N Elliott; S Asfaha; J L Wallace
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages.

Authors:  Michael Lazarus; Bruno Kilunga Kubata; Naomi Eguchi; Yasushi Fujitani; Yoshihiro Urade; Osamu Hayaishi
Journal:  Arch Biochem Biophys       Date:  2002-01-15       Impact factor: 4.013

6.  Lipid mediator class switching during acute inflammation: signals in resolution.

Authors:  B D Levy; C B Clish; B Schmidt; K Gronert; C N Serhan
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

7.  Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis.

Authors:  T Tanioka; Y Nakatani; N Semmyo; M Murakami; I Kudo
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

8.  Identification and characterization of a novel type of membrane-associated prostaglandin E synthase.

Authors:  Naomi Tanikawa; Yoshihiro Ohmiya; Hiroaki Ohkubo; Katsuyuki Hashimoto; Kenji Kangawa; Masami Kojima; Seiji Ito; Kikuko Watanabe
Journal:  Biochem Biophys Res Commun       Date:  2002-03-08       Impact factor: 3.575

9.  Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target.

Authors:  P J Jakobsson; S Thorén; R Morgenstern; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

10.  Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2.

Authors:  M Murakami; H Naraba; T Tanioka; N Semmyo; Y Nakatani; F Kojima; T Ikeda; M Fueki; A Ueno; S Oh; I Kudo
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157
View more
  28 in total

1.  Prostaglandin E2 Regulates Activation of Mouse Peritoneal Macrophages by Staphylococcus aureus through Toll-Like Receptor 2, Toll-Like Receptor 4, and NLRP3 Inflammasome Signaling.

Authors:  Jindi Wu; Bo Liu; Wei Mao; Shuang Feng; Yuan Yao; Fan Bai; Yuan Shen; Amu Guleng; Bayin Jirigala; Jinshan Cao
Journal:  J Innate Immun       Date:  2019-05-29       Impact factor: 7.349

2.  Novel human mPGES-1 inhibitors identified through structure-based virtual screening.

Authors:  Adel Hamza; Xinyun Zhao; Min Tong; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Bioorg Med Chem       Date:  2011-08-25       Impact factor: 3.641

Review 3.  The current progress in understanding the molecular functions and mechanisms of visfatin in osteoarthritis.

Authors:  Lele Liao; Yiyue Chen; Wanchun Wang
Journal:  J Bone Miner Metab       Date:  2016-03-11       Impact factor: 2.626

4.  Selective inhibitors of human mPGES-1 from structure-based computational screening.

Authors:  Ziyuan Zhou; Yaxia Yuan; Shuo Zhou; Kai Ding; Fang Zheng; Chang-Guo Zhan
Journal:  Bioorg Med Chem Lett       Date:  2017-06-29       Impact factor: 2.823

5.  Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats.

Authors:  Aline A da Cunha; Andréa G K Ferreira; Samanta O Loureiro; Maira J da Cunha; Felipe Schmitz; Carlos Alexandre Netto; Angela T S Wyse
Journal:  Neurochem Res       Date:  2012-04-08       Impact factor: 3.996

6.  Despite transcriptional and functional coordination, cyclooxygenase-2 and microsomal prostaglandin E synthase-1 largely reside in distinct lipid microdomains in WISH epithelial cells.

Authors:  William E Ackerman; John M Robinson; Douglas A Kniss
Journal:  J Histochem Cytochem       Date:  2005-06-27       Impact factor: 2.479

7.  Protective effects of isolated polyphenolic and alkaloid fractions of Ruta graveolens L. on acute and chronic models of inflammation.

Authors:  M Ratheesh; G L Shyni; G Sindhu; A Helen
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

Review 8.  Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology.

Authors:  Hedi Harizi
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

9.  Anti-inflammatory effect of quinoline alkaloid skimmianine isolated from Ruta graveolens L.

Authors:  M Ratheesh; G Sindhu; Antony Helen
Journal:  Inflamm Res       Date:  2013-01-24       Impact factor: 4.575

10.  Leukotriene B4 at low dosage negates the catabolic effect of prostaglandin E2 in human patellar tendon fibroblasts.

Authors:  Bhavani P Thampatty; Hee-Jeong Im; James H-C Wang
Journal:  Gene       Date:  2006-02-20       Impact factor: 3.688
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.